ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Durham, NC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Durham, NC, USA:

REAL-Fam Feasibility Study for Youth Diabetes Management

how a rural family participates in and manages their child's type 1 diabetes, their family quality of life, and the child's health outcomes....

Enrolling
Type 1 Diabetes
Behavioral: REAL-Fam Occupational Therapy Family Coaching
University of North Carolina (UNC)
University of North Carolina (UNC)

Chapel Hill, North Carolina, United States

The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...

Active, not recruiting
Diabetes Mellitus, Type 1
Other: TOL-3021 Placebo
Biological: TOL-3021

Phase 2

Tolerion

Chapel Hill, North Carolina, United States and 22 other locations

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Chapel Hill, North Carolina, United States and 26 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Wake Forest, North Carolina, United States of America and 24 other locations

The primary objective of this study is to demonstrate that KAI-9531 subcutaneous (SC) injection once weekly is superior to placebo on:* Percent chang...

Enrolling
Overweight With Diabetes
Obesity With Diabetes
Drug: KAI-9531
Drug: Placebo

Phase 3

Kailera

Greensboro, North Carolina, United States and 20 other locations

This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...

Not yet enrolling
Type II Diabetes Mellitus
Other: Placebo
Drug: CX11

Phase 2

Corxel Pharmaceuticals

Raleigh, North Carolina, United States and 45 other locations

Locations recently updated

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT/ rilparencel)
Procedure: Sham Comparator

Phase 3

Prokidney

Chapel Hill, North Carolina, United States and 96 other locations

IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Type 2 DM
Other: (IRIS-CKD Screening Program): Home Kit
Other: (IRIS-CKD Screening Program): Standard Lab Order
Duke University
Duke University

Durham, North Carolina, United States and 5 other locations

implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes...

Enrolling
Type 2 Diabetes Mellitus (T2DM)
Type 2 DM
Other: (IRIS-CKD Management Program): Education
Other: (IRIS-CKD Management Program): GDMT
Duke University
Duke University

Durham, North Carolina, United States and 5 other locations

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...

Enrolling
Type 1 Diabetes Patients
Type 1 Diabetes Mellitus
Drug: CNP-103
Drug: Placebo

Phase 1, Phase 2

COUR Pharmaceuticals

Durham, North Carolina, United States and 31 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems